ALLODERM
Device
ABBVIE INC.
Total Payments
$51.9M
Transactions
35,991
Doctors
6,199
Companies
5
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $7.4M | 3,502 | 1,300 |
| 2023 | $11.8M | 3,046 | 1,166 |
| 2022 | $22.3M | 94 | 79 |
| 2021 | $2,835 | 35 | 31 |
| 2020 | $217,552 | 72 | 31 |
| 2019 | $1.9M | 4,530 | 942 |
| 2018 | $3.7M | 11,449 | 2,731 |
| 2017 | $4.6M | 13,263 | 3,422 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $41.2M | 12 | 79.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5.4M | 2,007 | 10.3% |
| Travel and Lodging | $1.6M | 4,362 | 3.1% |
| Food and Beverage | $1.6M | 29,145 | 3.1% |
| Consulting Fee | $1.4M | 330 | 2.8% |
| Unspecified | $322,728 | 26 | 0.6% |
| Gift | $151,855 | 15 | 0.3% |
| Education | $140,547 | 72 | 0.3% |
| Grant | $64,715 | 21 | 0.1% |
| Space rental or facility fees (teaching hospital only) | $750.00 | 1 | 0.0% |
Payments by Type
General
$51.5M
35,965 transactions
Research
$322,728
26 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Th Use of AlloDerm coverage to reinforce tissues in two-stage expansion and implant placement in the subcutaneous pre-pectoral plane a prospective pilot study | Allergan Inc. | $90,000 | 0 |
| THE USE OF ALLODERM COVERAGE TO REINFORCE TISSUES IN TWO-STAGE EXPANSION AND IMPLANT PLACEMENT IN THE SUBCUTANEOUS (PRE-PECTORAL) PLANE: A PROSPECTIVE PILOT STUDY | Allergan, Inc. | $57,170 | 0 |
| COMPARISON OF HEALTHCARE RESOURCE UTILIZATION AND CLINICAL OUTCOMES BETWEEN DUAL PLANE AND PRE PECTORAL TECHNIQUES IN BREAST RECONSTRUCTION WITH ALLODERM A MULTICENTER RETROSPECTIVE CHART REVIEW | Allergan Inc. | $56,112 | 0 |
| The use of Alloderm Coverage to Reinforce Tissues in Two-Stage Tissue in two-stage tissue expansion and implant placement in the subcutaneous pre-pectoral plane a prospective pilot study | Allergan Inc. | $43,249 | 0 |
| A Comparison of Complication Rates Following Tissue Expander Breast Reconstruction | Allergan Inc. | $20,000 | 0 |
| Assessing Treatment Benefit Among Patients with Breast Reconstruction Patient Cognitive Interviews | Allergan Inc. | $13,795 | 0 |
| BREAST RECONSTRUCTION AFTER MASTECTOMY WITH BREAST IMPLANT IN ONE STAGE | Allergan Inc. | $11,452 | 0 |
| Breast Reconstruction after Mastectomy with Breast Implant in One Stage | Allergan Inc. | $11,452 | 0 |
| A COMPARISON OF COMPLICATION RATES FOLLOWING TISSUE EXPANDER BREAST RECONSTRUCTION | Allergan Inc. | $10,000 | 0 |
| Outcomes for Alloderm versus Alloderm Ready To Use in Immediate 2-stage Tissue ExpanderImplant Breast Reconstruction Following Skin-Sparing Total Mastectomy | Allergan Inc. | $5,000 | 0 |
| Comparison of Healthcare Resource Utilization and Clinical Outcomes between Dual Plane and Pre Pectoral Techniques in Breast Reconstruction with Alloderm A Multicenter Retrospective Chart Review | Allergan Inc. | $2,370 | 0 |
| ACELLULAR DERMAL MATRIX ADVICE | Allergan, Inc. | $2,128 | 1 |
Top Doctors Receiving Payments for ALLODERM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Plastic Surgery | Nashville, TN | $41.1M | 23 |
| , MD | Plastic and Reconstructive Surgery | San Francisco, CA | $645,820 | 621 |
| , MD | Surgery | Vancouver, WA | $533,008 | 362 |
| , MD | Emergency Medicine | Somerville, NJ | $532,578 | 27 |
| Unknown | — | Camden, NJ | $512,852 | 91 |
| Maurice Nahabedian | Plastic and Reconstructive Surgery | Washington, DC | $466,255 | 542 |
| , M.D | Plastic Surgery | New York, NY | $419,228 | 317 |
| , MD | Plastic Surgery | Milwaukee, WI | $418,705 | 344 |
| , MD | Surgery of the Hand | Glen Ellyn, IL | $336,751 | 342 |
| , MD | Plastic Surgery | Peoria, IL | $218,738 | 189 |
| , MD | Surgery | Vancouver, WA | $196,903 | 211 |
| , MD | Surgical Oncology | Charlotte, NC | $171,978 | 95 |
| , M.D.F.A.C.S | Plastic Surgery | Sea Girt, NJ | $158,033 | 43 |
| , MD | Surgery | Winfield, IL | $146,609 | 188 |
| , MD | Procedural Dermatology | Staten Island, NY | $144,431 | 19 |
| , MD | Plastic and Reconstructive Surgery | Orlando, FL | $111,728 | 133 |
| , MD | Surgery | Charlotte, NC | $110,210 | 117 |
| , M.D | Plastic Surgery | San Diego, CA | $105,930 | 113 |
| , M.D | Plastic Surgery | Annapolis, MD | $96,165 | 119 |
| , M.D | Plastic Surgery | Rochester, MN | $92,031 | 85 |
| , M.D | Plastic Surgery | Chevy Chase, MD | $91,973 | 112 |
| , MEDICAL DOCTOR | Specialist | Eugene, OR | $86,718 | 74 |
| , MD | Plastic and Reconstructive Surgery | Baltimore, MD | $86,487 | 74 |
| , M.D | Specialist | Eugene, OR | $80,017 | 64 |
| Michael Bauer | Blood Banking & Transfusion Medicine | Castle Rock, CO | $79,789 | 10 |
Ad
Manufacturing Companies
- ABBVIE INC. $41.3M
- Allergan Inc. $10.0M
- Allergan, Inc. $378,961
- AbbVie Inc. $99,199
- KCI USA, Inc $3,693
Product Information
- Type Device
- Total Payments $51.9M
- Total Doctors 6,199
- Transactions 35,991
About ALLODERM
ALLODERM is a device associated with $51.9M in payments to 6,199 healthcare providers, recorded across 35,991 transactions in the CMS Open Payments database. The primary manufacturer is ABBVIE INC..
Payment data is available from 2017 to 2024. In 2024, $7.4M was paid across 3,502 transactions to 1,300 doctors.
The most common payment nature for ALLODERM is "Royalty or License" ($41.2M, 79.4% of total).
ALLODERM is associated with 12 research studies, including "Th Use of AlloDerm coverage to reinforce tissues in two-stage expansion and implant placement in the subcutaneous pre-pectoral plane a prospective pilot study" ($90,000).